Literature DB >> 10416517

Does tuberculosis accelerate the progression of HIV disease? Evidence from basic science and epidemiology.

J Del Amo1, A S Malin, A Pozniak, K M De Cock.   

Abstract

Entities:  

Mesh：

Year:  1999        PMID： 10416517     DOI： 10.1097/00002030-199907090-00002

Source DB:  PubMed          Journal:  AIDS        ISSN： 0269-9370            Impact factor:   4.177


× No keyword cloud information.
  15 in total

1.  Immunoadjuvant prednisolone therapy for HIV-associated tuberculosis: a phase 2 clinical trial in Uganda.

Authors:  Harriet Mayanja-Kizza; Edward Jones-Lopez; Alphonse Okwera; Robert S Wallis; Jerrold J Ellner; Roy D Mugerwa; Christopher C Whalen
Journal:  J Infect Dis       Date:  2005-02-08       Impact factor: 5.226

Review 2.  Effect of treating co-infections on HIV-1 viral load: a systematic review.

Authors:  Kayvon Modjarrad; Sten H Vermund
Journal:  Lancet Infect Dis       Date:  2010-07       Impact factor: 25.071

3.  Distribution of the human immunodeficiency virus coreceptors CXCR4 and CCR5 on leukocytes of persons with human immunodeficiency virus type 1 infection and pulmonary tuberculosis: implications for pathogenesis.

Authors:  S Shalekoff; S Pendle; D Johnson; D J Martin; C T Tiemessen
Journal:  J Clin Immunol       Date:  2001-11       Impact factor: 8.317

4.  Impact of pulmonary tuberculosis on survival of HIV-infected adults: a prospective epidemiologic study in Uganda.

Authors:  C C Whalen; P Nsubuga; A Okwera; J L Johnson; D L Hom; N L Michael; R D Mugerwa; J J Ellner
Journal:  AIDS       Date:  2000-06-16       Impact factor: 4.177

5.  Tuberculosis (TB) and HIV infection are independently associated with elevated serum concentrations of tumour necrosis factor receptor type 1 and beta2-microglobulin, respectively.

Authors:  S D Lawn; D Rudolph; S Wiktor; D Coulibaly; A Ackah; R B Lal
Journal:  Clin Exp Immunol       Date:  2000-10       Impact factor: 4.330

Review 6.  Contribution of immune activation to the pathogenesis and transmission of human immunodeficiency virus type 1 infection.

Authors:  S D Lawn; S T Butera; T M Folks
Journal:  Clin Microbiol Rev       Date:  2001-10       Impact factor: 26.132

Review 7.  Cotrimoxazole prophylaxis for opportunistic infections in adults with HIV.

Authors:  K Grimwade
Journal:  Cochrane Database Syst Rev       Date:  2003

8.  Effect of tuberculosis on the survival of HIV-infected men in a country with low tuberculosis incidence.

Authors:  Hugo López-Gatell; Stephen R Cole; Joseph B Margolick; Mallory D Witt; Jeremy Martinson; John P Phair; Lisa P Jacobson
Journal:  AIDS       Date:  2008-09-12       Impact factor: 4.177

9.  Prevalent and incident tuberculosis are independent risk factors for mortality among patients accessing antiretroviral therapy in South Africa.

Authors:  Ankur Gupta; Robin Wood; Richard Kaplan; Linda-Gail Bekker; Stephen D Lawn
Journal:  PLoS One       Date:  2013-02-13       Impact factor: 3.240

10.  Active tuberculosis is associated with worse clinical outcomes in HIV-infected African patients on antiretroviral therapy.

Authors:  Abraham M Siika; Constantin T Yiannoutsos; Kara K Wools-Kaloustian; Beverly S Musick; Ann W Mwangi; Lameck O Diero; Sylvester N Kimaiyo; William M Tierney; Jane E Carter
Journal:  PLoS One       Date:  2013-01-02       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.